| Date | Time | Source | Headline | Symbol | Company |
| 08/06/2010 | 9:30AM | Marketwired | Research on Forest Laboratories and Cephalon -- Generic Drugs Making Great Strides | NYSE:FRX | Forest Road Acquisition Corp |
| 07/29/2010 | 9:31AM | PR Newswire (US) | Critical Alerts for Microsoft, Alcoa, Bank of New York Mellon, Bunge, and Forest Laboratories Released by Seven Summits Research | NYSE:FRX | Forest Road Acquisition Corp |
| 07/23/2010 | 10:08AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/22/2010 | 8:00AM | Business Wire | Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KGaA Settle NAMENDA® Patent Litigation | NYSE:FRX | Forest Road Acquisition Corp |
| 07/20/2010 | 3:12PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/20/2010 | 11:40AM | Dow Jones News | CORRECT: Forest Labs 1Q Profit Down 55% On Charges; EPS View Raised | NYSE:FRX | Forest Road Acquisition Corp |
| 07/20/2010 | 9:02AM | Dow Jones News | Forest Labs 1Q Profit Down 55% On Charges; EPS View Raised | NYSE:FRX | Forest Road Acquisition Corp |
| 07/20/2010 | 8:00AM | Business Wire | Forest Laboratories, Inc. Reports First Quarter FY 2011 EPS of $0.39, Including $0.39 Per Share Charge Related to Settlement ... | NYSE:FRX | Forest Road Acquisition Corp |
| 07/08/2010 | 3:01PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/07/2010 | 8:38AM | Business Wire | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2011 First Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 07/06/2010 | 9:33AM | Dow Jones News | CORRECT: Nycomed: EU Approves Daxas To Treat Smoker's Lung | NYSE:FRX | Forest Road Acquisition Corp |
| 07/06/2010 | 9:28AM | Dow Jones News | 2nd UPDATE: Nycomed: EU Approves Daxas To Treat Smoker's Lung | NYSE:FRX | Forest Road Acquisition Corp |
| 07/06/2010 | 8:40AM | Dow Jones News | UPDATE: Nycomed: EU Approves Daxas For Use In Smoker's Lung | NYSE:FRX | Forest Road Acquisition Corp |
| 06/28/2010 | 4:15PM | Business Wire | Forest Laboratories, Inc. & Gedeon Richter Announce Results from a Phase II Study of Radiprodil for the Treatment of Diabetic... | NYSE:FRX | Forest Road Acquisition Corp |
| 06/21/2010 | 5:12PM | Business Wire | Forest and Merz Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer’s Type | NYSE:FRX | Forest Road Acquisition Corp |
| 06/17/2010 | 3:50PM | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/14/2010 | 1:53PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/09/2010 | 11:57AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/09/2010 | 11:57AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/09/2010 | 11:56AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/09/2010 | 8:00AM | Business Wire | Forest Laboratories, Inc. Announces Accelerated Share Repurchase | NYSE:FRX | Forest Road Acquisition Corp |
| 06/08/2010 | 9:00AM | Dow Jones News | Forest Labs, TransTech In Licensing Deal For Up To $1.11 Billion | NYSE:FRX | Forest Road Acquisition Corp |
| 06/08/2010 | 8:00AM | Business Wire | Forest Laboratories & TransTech Pharma Enter Into License Agreement for the Development & Commercialization of Glucokinase Ac... | NYSE:FRX | Forest Road Acquisition Corp |
| 06/08/2010 | 8:00AM | Business Wire | Forest Laboratories & TransTech Pharma Enter Into License Agreement for the Development & Commercialization of Glucokinase Ac... | NYSE:FRX | Forest Road Acquisition Corp |
| 05/19/2010 | 9:31AM | PR Newswire (US) | Critical Alerts for Google, Pfizer, Newmont Mining, Forest Laboratories, and Accenture Released by Seven Summits Research | NYSE:FRX | Forest Road Acquisition Corp |
| 05/18/2010 | 8:41AM | Business Wire | Forest Laboratories, Inc. Announces New Share Repurchase Program | NYSE:FRX | Forest Road Acquisition Corp |
| 05/17/2010 | 6:45PM | Business Wire | Forest Laboratories and Nycomed Receive Complete Response Letter for Roflumilast | NYSE:FRX | Forest Road Acquisition Corp |
| 05/11/2010 | 2:30AM | Business Wire | Forest & Almirall to Present Data from Studies of Aclidinium Bromide in Chronic Obstructive Pulmonary Disease (COPD) & LAS100... | NYSE:FRX | Forest Road Acquisition Corp |
| 05/10/2010 | 2:00AM | Business Wire | Forest and Nycomed to Present Results from Six Roflumilast Posters | NYSE:FRX | Forest Road Acquisition Corp |
| 05/06/2010 | 10:15AM | Dow Jones News | Sun Pharmaceutical Gets U.S. OK For Generic Namenda Tablets | NYSE:FRX | Forest Road Acquisition Corp |